Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 16 2020

Full Issue

Rapid COVID-19 Testing Is Less Accurate Than Earlier Studies Indicated

In related news, airport screening effectiveness, algorithm-aided tracking and more.

ProPublica: Rapid Testing Is Less Accurate Than The Government Wants To Admit 

The promise of antigen tests emerged like a miracle this summer. With repeated use, the theory went, these rapid and cheap coronavirus tests would identify highly infectious people while giving healthy Americans a green light to return to offices, schools and restaurants. The idea of on-the-spot tests with near-instant results was an appealing alternative to the slow, lab-based testing that couldn’t meet public demand. (Song, 11/16)

Science Alert: Rapid COVID-19 Antibody Test Is Not As Accurate As We Were Told, Scientists Warn

A rapid finger-prick test designed to show whether a person has previously been infected with SARS-CoV-2 is significantly less accurate than earlier research suggested, scientists report in a new study. The AbC-19 Rapid Test, developed for use by healthcare professionals in the UK and EU, looks for antibodies against the virus in a small drop of blood from a finger-prick, and can show results in just 20 minutes, without needing specialised lab equipment. (Dockrill, 11/16)

In related news on testing, tracing and screening —

CIDRAP: CDC: Symptom-Based COVID-19 Airport Screening Ineffective

Data published today in Morbidity and Mortality Weekly Report (MMWR) shows that resource-intensive, symptom-based airline passenger entry screening identified few laboratory-diagnosed COVID-19 cases—only 1 case for every 85,000 travelers screened. The researchers also highlight the inadequacy of electronic airline data for contact tracing, finding that only 22% of records contain both the traveler's phone number and physical address. (11/13)

The Wall Street Journal: Meat Giant Tyson Girds For Virus Surge, Tracking Covid-19 With Algorithms 

Tyson Foods Inc. is using infection-tracking algorithms and ongoing employee testing to shield workers at the biggest U.S. meatpacker from a fresh surge in coronavirus cases and keep grocery stores stocked, its chief executive said. The Arkansas-based company, like other meatpackers, is spending heavily on protective gear and planning longer-term defenses against Covid-19. Tyson Chief Executive Dean Banks said the company is adding more space for workers at existing plants and designing new ones to include workstation dividers and other safeguards. (Bunge, 11/15)

Wired: That Pre-Thanksgiving Covid Test Won't Really Keep You Safe 

It’s true that getting a positive result tells you some crucial information: It’s time to cancel all your plans and isolate until you’re past the point of infectiousness. A negative test, though, doesn’t guarantee that anyone is Covid-free, and it’s never license to let down your guard. You might, for instance, contract the virus in the interim between being tested and receiving your results, or between getting your results and seeing your friends and family. (The testing site itself could even be where that happens.) Even if you assume these tests are 100 percent accurate, they’ll only tell you what your status is at the specific time the test is done. (Aschwanden, 11/15)

The Washington Post: Covid Risk And Tracking Tools: How To Use Them Safely 

For many Americans these days, the mere idea of leaving the house prompts a question: “What’s the risk?” And often, they find that even after scrutinizing data on novel coronavirus cases and poring over public health recommendations, there still isn’t a clear answer. (Chiu, 11/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF